ADMA
$16.26
Revenue | $107.19Mn |
Net Profits | $32.06Mn |
Net Profit Margins | 29.91% |
Adma Biologics Inc’s revenue jumped 78.29% since last year same period to $107.19Mn in the Q2 2024. On a quarterly growth basis, Adma Biologics Inc has generated 30.92% jump in its revenue since last 3-months.
Adma Biologics Inc’s net profit jumped 603.27% since last year same period to $32.06Mn in the Q2 2024. On a quarterly growth basis, Adma Biologics Inc has generated 80.06% jump in its net profits since last 3-months.
Adma Biologics Inc’s net profit margin jumped 382.28% since last year same period to 29.91% in the Q2 2024. On a quarterly growth basis, Adma Biologics Inc has generated 37.54% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.13 |
EPS Estimate Current Year | 0.13 |
Adma Biologics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.13 - a 62.5% jump from last quarter’s estimates.
Adma Biologics Inc’s earning per share (EPS) estimates for the current year stand at 0.13.
Earning Per Share (EPS) | 0.13 |
Adma Biologics Inc’s earning per share (EPS) jumped 533.33% since last year same period to 0.13 in the Q2 2024. This indicates that the Adma Biologics Inc has generated 533.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-09 | 0.06 | 0.08 | 33.33% |
2024-08-08 | 0.08 | 0.13 | 62.5% |